Search fresh public links, source activity, and ready-to-use post angles for Gsk.
Fresh curated links around GSK are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
With its latest foray into China, GSK acquired rights from Hutchmed to an “antibody-targeted therapy conjugate” impacting two well-known cancer drivers, EGFR and KRAS.
GSK is acquiring global rights to a T cell engager that Chimagen Biosciences developed to hit three targets. GSK believes this tri-specific approach could offer advantages over cur...
What a difference 12 years make. In 2014 GlaxoSmithKline was fined £300m by a Chinese court for running a 'massive bribery network'.
GSK gained rights to a Hutchmed antibody-targeted therapy conjugate, or ATTC. This new type of targeted therapy blocks two cancer-driving proteins and will initially be developed f...
GSK plans to invest more than $800 million in its Upper Merion, Pennsylvania, site, adding drug manufacturing, research, and quality testing facilities.
GSK has committed to carbon credits from an Indian regenerative agriculture project as the pharmaceutical group expands its use of nature-based climate solutions. The eight-year pu...
The biopharmaceutical maker plans to establish a manufacturing hub with a quality control lab and plant for technology and process development. It is expected to create 300 jobs.
Harvey Jones backed the GSK share price to spring into life a couple of years ago, but it's still struggling to make headway. Why isn't it doing better? The post Trading below leve...
GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of the virus. That could be an advantage over Moderna’s r...
Vaccine production in Germany's Dresden is set to end after 115 years, with pharmaceutical group GlaxoSmithKline (GSK) announcing plans on Thursday to close its site in the eastern...
Harvey Jones is fascinated to see GSK shares are suddenly the most purchased stock of all, and wonders what's behind its sudden popularity. The post Why is everybody suddenly buyin...
Hibsago is viewed as a potential “functional cure” for chronic infections and an important part of the British drugmaker’s goal of reaching £40 billion in annual revenue by 2031.
The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular genetic signature. It’s a label expansion for Jemperli, wh...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.